Form 4: Orthofix Medical Inc. Executive Max Reinhardt Reports Acquisition and Disposal of Shares

Max Reinhardt, President of Global Spine at Orthofix Medical Inc., reports acquiring and disposing of common stock and employee stock options.

Summary

• On March 3, 2025, Max Reinhardt, President of Global Spine at Orthofix Medical Inc., reported transactions involving the company's securities.
• Reinhardt acquired 14,723 shares of common stock.
• He also disposed of 29,124 shares.
• Additionally, Reinhardt acquired 34,924 employee stock options with an exercise price of $16.98, exercisable in thirds on the first, second, and third anniversaries of the grant date, expiring on March 3, 2032.
• Following these transactions, Reinhardt beneficially owns 29,124 shares of common stock and 34,924 derivative securities.

Sentiment

Score: 5

Explanation: The sentiment is neutral. The form indicates both acquisition and disposal of shares, making it difficult to gauge a clear positive or negative outlook. The acquisition of stock options is mildly positive.

Positives

• The acquisition of employee stock options suggests confidence in the company's future performance.

Negatives

• The disposal of 29,124 shares could be interpreted negatively by investors, although the reason for disposal is not specified.

Risks

• The disposal of a significant number of shares by an executive could potentially signal concerns about the company's prospects, although this is not explicitly stated.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding insider transactions in publicly traded companies. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• Shareholders may react to the reported transactions, potentially influencing the stock price.

Key Dates